Industry: Health care Region: Greece Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
Founded in 2006, Greek Bio-Cluster has more than 85 member units. It is an early and large-scale health and biotechnology cluster in Greece. It is initiated and independent by the Greek Research and Technology Foundation (FORTH) and brings together innovative leading enterprises in the fields of pharmacy, biotechnology, diagnosis, medical devices and related professional services in Greece. The cluster has 13,000 employees and created a market output value of 80 million euros, with a market share of 3.9 billion euros and exports of 1.1 billion euros. Cluster has created a powerful ecosystem, which includes the main research institutions in Greece (FORTH, CERTH, BRFAA, BSRC Alexander Fleming, NCSR Demokritos), major partners in universities and pharmaceutical industries, small and medium-sized enterprises, start-ups and derivative enterprises from the whole health and biotechnology industry, and has become a powerful regulator and promoter of the innovation process of Greek biotechnology industry.
product
Diagnostic kit
The member units of Greek Biocluster have a series of diagnostic kits and medical devices for sale in China, including PoC systems for personalized medical care, tumor diagnosis, infectious diseases and ophthalmic diseases.
Application fields: biopharmaceuticals, public health, medical equipment, product development.
Seeking: manufacturer, license partner, investment/financing.
service
Provide a series of CRO services for biopharmaceutical industry in China, including generic drugs, clinical trial support, EU regulations support, reuse, drug development, PoC diagnostic medical device design, imaging services, bioinformatics, e-health applications, etc.
Seeking: investment/financing, technology transfer, innovation management, research and development, supply chain management, project cooperation.